MTX1 Knockout Raji Polyclonal Cells consist of a CRISPR/Cas9-edited polyclonal Raji cell population with targeted disruption of the MTX1 gene. This loss-of-function model provides a heterogeneous pool of knockout cells ideal for studying mitochondrial biology and apoptosis without clonal selection artifacts. The polyclonal format maintains genetic diversity, enabling robust functional analyses directly in the Raji B lymphocyte background.
The Raji cell line is an Epstein-Barr virus-positive Burkitt??s lymphoma-derived B lymphocyte model widely employed in immunology and cancer research. Its rapid growth and well-characterized signaling pathways make it suitable for investigating mitochondrial function in the context of humoral immunity and B cell malignancies. The EBV-positive status further provides a relevant platform to examine how mitochondrial dysregulation influences viral oncogenesis and cell survival.
MTX1 encodes metaxin-1, a mitochondrial outer membrane protein that collaborates with SAM50 and metaxin-2 to mediate import of nuclear-encoded mitochondrial carrier proteins, such as the SLC25 family. This process is critical for mitochondrial metabolite exchange and metabolic integrity. Moreover, MTX1 participates in apoptosis regulation by modulating the balance of pro-apoptotic BAX and anti-apoptotic BCL2 family members. Stress signals are hypothesized to regulate MTX1, linking mitochondrial protein import machinery to cell death pathways.
In Raji B cells, MTX1 disruption is expected to impair mitochondrial carrier protein import, resulting in metabolic stress and heightened sensitivity to apoptotic stimuli. This model thus enables dissection of mitochondrial proteostasis in rapidly proliferating lymphoma cells and its impact on B cell survival. The polyclonal knockout pool mirrors tumor heterogeneity, offering a physiologically relevant system to study mitochondrial dysfunction in lymphoid malignancies.
This product supports diverse assays, including Western blotting for MTX1 expression, co-immunoprecipitation for SAM50 or MTX2 interactions, mitochondrial membrane potential measurements, and annexin V/flow cytometry apoptosis assays. Applications encompass mitochondrial protein import, apoptosis signaling in B lymphocytes, and mitochondrial dysfunction in Burkitt??s lymphoma. The MTX1 Knockout Raji Polyclonal Cells are a versatile platform for functional genomics and pharmacological screening. For further details, contact Ascent Research.
